Sodium hyaluronate (hyaluronic acid or hyaluronan) is a naturally occurring, highmolecular-mass, polysaccharide present in the extracellular matrix of connective tissues. It is also found in the aqueous humor and the vitreous and coats the corneal endothelium (Balazs 1983) . Sodium hyaluronate, and other viscoelastic substances including methylcellulose, chondroitin sulfate, polyacrylamide, and collagen, have been used in intraocular surgery since the 1970s (Liesegang 1990) .
Since the introduction of Healon ® (sodium hyaluronate 1%, 4 × 10 6 daltons) in 1979 (Balazs et al 1979) , sodium hyaluronate has become the most popular and indispensable viscoelastic substance for use in intraocular surgery. Comprehensive reviews published since then have described pharmacological, physiological, and clinical aspects of sodium hyaluronate in ophthalmologic applications in detail (Liesegang 1990; Goa and Benfi eld 1994) . Along with the advent of a new generation of sodium hyaluronates, these compounds rapidly became essential tools for integral parts of intraocular surgery; and the term ophthalmic viscosurgical devices (OVDs) for viscoelastic substances was introduced in the beginning of this century. This review focuses on recent developments in the application of sodium hyaluronates to various intraocular surgeries.
Sodium hyaluronate in the early 1990s
In the early 1990s, sodium hyaluronate agents could be classifi ed as cohesive (eg, Healon ® ; HealonGV ® , sodium hyaluronate 1.4%, 5 × 10 6 daltons) or dispersive (eg, Viscoat ® , sodium hyaluronate 3%, 5 × 10 5 daltons -chondroitin sulfate 4%). Cohesiveness, which means the degree to which a material adheres to itself, is a function of molecular weight and elasticity and is proportional to the viscosity (a measure of its resistance to fl ow) at zero shear rate (Liesegang 1990 ). The viscosity is a function of the molecular weight, concentration, and temperature. The plot of dynamic viscosity against shear rate (lower viscosity at higher shear rate) reveals the pseudoplasticity of sodium hyaluronate. High pseudoplasticity facilitates injection of sodium hyaluronate through a small-gauge cannula. Elasticity is the tendency of a material to return to its original shape after being stretched or compressed. Long-chain molecules tend to be more elastic than short-chain molecules.
Cohesive agents have long molecular chains (high molecular weight) and are strongly entangled, whereas dispersive agents have low molecular weight and short molecular chains. Maintenance of anterior chamber depth and easy removal by aspiration are desirable consequences of cohesiveness, whereas coating the corneal endothelium is best done with dispersive materials.
New generation of sodium hyaluronate agents

Healon
® 5
In 1998, a new sodium hyaluronate agent, Healon ® 5 (sodium hyaluronate 2.3%, 4 × 10 6 daltons), was introduced. Because of its higher concentration, Healon ® 5 has even higher viscosity at rest (7 × 10 6 mPa и s) than superviscous cohesive HealonGV ® (2 × 10 6 mPa и s). Healon ® 5 behaves like the superviscous cohesives at low shear rate, but its distinguishing property, which is solid-like behavior due to its rigid molecular structure, appears at high shear rate. The biphasic behavior of Healon ® 5 created a new class of OVDs termed viscoadaptive (Arshinoff 1999A) . Healon ® 5 is also called pseudodispersive because fracturing that occurs due to its high rigidity before being sucked into the irrigation/aspiration port makes its complete removal more diffi cult than removal of cohesive OVDs. In contrast, dispersive OVDs such as Viscoat ® are resistant to aspiration because lack of suffi cient cohesion allows only small pieces to be aspirated at a time (Arshinoff and Wong 2003 removal techniques are commonly used. One is the rock'n roll technique in which the irrigation/aspiration handpiece is moved in a circular fashion in the anterior chamber at the iris plane using gentle pressure with the handpiece on the edge of the IOL optic (Arshinoff 1997) . The other is a two-compartment (behind-the-lens) technique in which the irrigation/aspiration tip is fi rst placed behind the IOL optic to remove the OVD in the capsular bag while the anterior chamber is still fi lled with the OVD, and then it is moved into the anterior chamber to remove the remaining OVD there (Tetz and Holzer 2000) . In a prospective randomized study of 159 patients comparing the two removal techniques, the two-compartment technique had a signifi cantly shorter mean Healon ® 5-removal time and a lower mean IOP 5 hours after surgery than did the rock'n roll technique, suggesting that the two-compartment technique is more effective than the rock'n roll technique (Zetterström et al 2002) .
However, for surgeons who do not like to place the irrigation/aspiration tip behind the IOL, Cionni et al (2004) to the OVD classifi cation due to its zero-shear viscosity, but its dispersive property does not fi t this classifi cation. Earlier OVDs had a cohesion property that correlated highly with zero-shear viscosity. The dissociation of viscosity and cohesion in DisCoVisc ® was discovered by measurement of OVD cohesion with the Poyer assay method (Poyer et al 1998) . A new OVD classifi cation was defi ned using zero-shear viscosity and cohesion independently (Arshinoff and Jafari 2005) . The dispersive property of DisCoVisc ® was confi rmed in several studies. OVD retention was measured between the corneal endothelium and the anterior chamber using in vivo confocal microscopy after simulated phacoemulsifi cation in rabbit eyes (Petroll et al 2005 VisThesia ® VisThesia ® is composed of 2 products: VisThesia Topical (sodium hyaluronate 0.3%, lidocaine 2%), for corneal hydration and topical anesthesia, and VisThesia Intracameral (sodium hyaluronate 1.5% and lidocaine 1%), for highviscosity, cohesive OVD and intracameral anesthesia. Randomized trials found that intracameral lidocaine 1% used as a supplement to topical anesthesia may slightly reduce patients discomfort and may not be toxic to the corneal endothelial cells when applied once prior to capsulorhexis (Carino et al 1998; Garcia et al 1998; Tseng and Chen 1998; Gillow et al 1999 should be similar to those of sodium hyaluronate 1.5% because a mixture of lidocaine 1.0% with sodium hyaluronate 1.5% does not signifi cantly alter its removal time from the capsular bag of postmortem human eyes (Pandey 2003) .
Cataract surgery
The main purpose for using sodium hyaluronate in cataract surgery is to maintain a stable anterior chamber depth and protect the corneal endothelial cells from being damaged during the entire surgical procedure. The advent of sodium hyaluronate with different rheologic properties has promoted the development of techniques in cataract surgery that decrease surgical complications and make challenging cases easier. However, postoperative elevation of IOP as an adverse effect of using sodium hyaluronate still remains a matter of concern for most surgeons.
Soft-shell technique
The technique (Arshinoff 1999B) , sodium hyaluronate 2.5%) with which the anterior chamber is fi lled to the desired extent (for capsulorhexis, 60%-80%; for capsular staining, 90%; for Higashide and Sugiyama IOL implantation, 60%). The technique reduces the resistance to advancing the capsulorhexis with a needle or forceps while maintaining tamponade to the lens surface well, and also reduces the amount of dye required for capsular staining of mature or white cataracts. Furthermore, this technique can be applied to the IOL implantation followed by an easy aspiration of OVDs in a way similar to the empty-bag technique described by Cionni et al (2004) .
Intraoperative fl oppy iris syndrome (IFIS) Chang and Campbell (2005) reported a new small-pupil syndrome associated with tamsulosin, a systemic α-1 blocker used to treat benign prostatic hypertrophy. The clinical intraoperative triad of the syndrome consists of fl uttering and billowing of the iris stroma caused by ordinary intraocular fl uid currents, a propensity for iris prolapse through the phacoemulsifi cation and/or side-port incisions, and progressive constriction of the pupil during surgery. In a prospective study of 900 consecutive cataract surgeries, they found the prevalence of IFIS to be 2.2%, and 94% of the IFIS cases had a history of taking systemic tamsulosin. In order to complete cataract surgery safely in eyes with IFIS syndrome, Healon ® 5 may help to mechanically expand the pupil (viscomydriasis) and prevent the iris from prolapsing by adding tone to the iris (Chang and Campbell 2005) . Furthermore, Arshinoff (2006) 
Capsulorhexis in pediatric cataract surgery
Since the introduction by Gimbell and Neuhann (1990) , CCC has become a standard technique in cataract surgery. However, there are challenging cases in which it is diffi cult to complete CCC. Among them, pediatric cataract is one of the most diffi cult categories because the pediatric lens capsule is more elastic than the adult lens capsule and the posterior pressure which pushs up the lens is higher in pediatric eyes than in adult eyes. By using Healon ® 5, Jeng et al (2004) successfully performed CCC in 9 of 10 eyes (6.4 ± 1.4 years), but they completed only 7 of 15 eyes with Healon ® or Viscoat ® (7.6 ± 1.4 years). Furthermore, even in much younger cases (median age of surgery = 9 months; range, 1-54 months), Gibbon and Quinn (2006) 
Anterior lens capsule staining with dyes
Indocyanine green (Horiguchi et al 1998) and trypan blue (Melles et al 1999B) are widely used for better visualization of the anterior lens capsule during CCC in diffi cult cases such as white or brunescent cataracts. In order to prevent dyes from staining other intraocular structures excessively, OVDs are used concomitantly, but controlling the staining area is sometimes diffi cult. In this regard, Arshinoff (2002) reported the usefulness of the ultimate soft-shell technique for capsular staining as described above. Marques et al (2004) reported a similar 3-step technique that prevents uncontrolled dispersion and excessive accumulation of dye within an OVD. They injected Healon ® 5 to fi ll the anterior chamber, then injected balanced salt solution gently onto the anterior lens capsule, and fi nally injected the dye slowly through a specially-designed 27-gauge cannula.
Postoperative complications and OVDs
IOP elevation by OVDs
A number of studies have shown that all viscoelastic substances are capable of increasing IOP in the early postoperative period (Liesegang 1990; Goa and Benfi eld 1994) . The IOP elevation by viscoelastic substances is caused by a reduction of aqueous outfl ow due to blockage of the trabecular meshwork where the fl uids exit the eye. Therefore, complete removal of OVDs is recommended after IOL implantation. The IOP elevation is usually transient, peaking at 4 to 7 hours postoperatively and returning to baseline within several days, but the maximum IOP may exceed 30 mmHg. Therefore, careful monitoring of IOP and IOP-lowering therapy may be necessary, especially in patients with glaucoma who have a compromised outfl ow facility. Molecular characteristic of OVDs should have signifi cant effects on the likelihood of IOP elevation. Torngren et al (2000) found positive correlations between concentration and maximum IOP increase and between molecular weight and time to peak in rabbit eyes after aqueous exchange with OVDs. However, no consensus has been reached among clinical studies as to which OVD causes most or least elevation of IOP postoperatively in cataract surgery. The lack of consensus is due partly to the variability of patient characteristics , the amount of OVDs remaining in the eye at the end of surgery, and the timing of IOP measurements (Rainer et al 2005) . For example, Viscoat ® , an OVD with low-molecular weight and short chain, is supposed to pass through the trabecular meshwork easily and be less likely to cause IOP elevation, whereas it is most resistant to complete removal due to its dispersive property. Rainer et al (2005) reported signifi cant IOP increases during the fi rst 24 hours, peaking at 1 hour after surgery (13.4 ± 9.4 mm Hg), in eyes that were operated with Viscoat A fl uorescently-labeled OVD enabled better visualization, facilitated complete removal, and caused a signifi cantly smaller IOP increase than a clear OVD (Smith and Burt 1992) . Although this technique has not become a routine procedure yet, it has been used in experimental studies with ex vivo eyes to examine retention or removal of OVDs during cataract surgery (Auffarth et al 2004A; Auffarth et al 2004B; Bissen-Miyajima 2006; Oshika et al 2006) .
Mechanism of corneal endothelial cell loss during cataract surgery and the protection by OVDs
During cataract surgery, mechanical damage from surgical instruments or lens fragments may cause corneal endothelial cell loss, and OVDs have been used for protection since the era of extracapsular cataract extraction began. In addition, ultrasound phacoemulsifi cation causes formation of highly reactive free radicals that are generated by the heat from cavity-implosion of decomposed water (Shimmura et al 1992; Holst et al 1993) . The free radicals induce oxidative tissue damage including corneal endothelial cell loss. In this regard, OVDs could reduce the amount of free radicals produced by phacoemulsifi cation in experimental studies (Shimmura et al 1992; Holst et al 1993; Takahashi et al 2002; Camillieri et al 2004; Takahashi et al 2006) and also in a clinical study (Augustin and Dick 2004) . Takahashi et al (2006) showed that an OVD's inhibitory effect against free radical formation in the phacoemulsifi cation simulations with an eye model was compatible with its retention properties in the anterior chamber under different irrigation/aspiration settings, and that Viscoat ® , with a high irrigation/aspiration setting, was superior to Healon ® , Opegan ® (sodium hyaluronate 1%, 0.6-1.2 × 10 6 daltons) and Healon ® 5 in suppression of free radical formation. The heat generation by phacoemulsification, which contributes not only to the corneal endothelial cell loss but also to wound burn and breakdown of the bloodaqueous barrier, was considered by Jurowski et al (2006) by measuring the increase in corneal surface temperature of rabbit eyes during phacoemulsifi cation. They suggested that dispersive OVDs may be more effective in preventing thermal injury.
Glaucoma surgery
To improve surgical outcome and reduce intraoperative and postoperative complications, sodium hyaluronate has been used for glaucoma surgeries including trabeculectomy and goniotomy. Furthermore, Stegmann et al (1999) established a new non-penetrating glaucoma surgery, viscocanalostomy, using Healon GV ® .
Trabeculectomy -intraoperative use of sodium hyaluronate
Prior to the era of routine use of the antimetabolites mitomycin C (Kitazawa et al 1991) and 5-fluorouracil (Heuer et al 1984) , excess filtration immediately after trabeculectomy was considered to be necessary for long-term surgical success, especially in diffi cult cases, but was likely to cause complications such as a flat anterior chamber and hypotony. To solve this problem, a number of studies evaluated the effectiveness of viscous and non-infl ammatory sodium hyaluronate in reducing early postoperative complications. In studies with a prospective and randomized design, intracameral or subconjunctival injection of sodium hyaluronate resulted in less frequent hypotony or fl attening of the anterior chamber (Alpar 1986; Charteris et al 1991; Barak et al 1992; Gulkilik et al 2006) , although negative results were also reported (Hung 1985; Teekhasaenee and Ritch 1986; Raitta et al 1994; Lopes et al 2006) . The inconsistency of the results may stem from the variability of surgical techniques, especially the site and the time that the sodium hyaluronate remained in the eye. As pointed out by Fiore et al (1989) , a postoperative shallow anterior chamber may cause corneal endothelial cell loss. The intracameral injection of sodium hyaluronate prior to trabeculectomy, which was randomly assigned, signifi cantly reduced corneal endothelial cell loss without the use of antimetabolites and intraoperative aspiration of sodium hyaluronate (Barak et al 1992) or with adjunctive mitomycin C and intraoperative removal of sodium hyaluronate (Shin et al 2003) . Wilson and Lloyd (1986) found a lower incidence of postoperative hyphema in eyes treated with intracameral sodium hyaluronate and attributed the effect to possible microvascular clotting and a mechanical force by sodium hyaluronate, whereas Raitta et al (1994) reported opposite results. As for bleb morphology, subconjunctival injection of Healon ® 5 at the conclusion of trabeculectomy with adjunctive antimetabolites (mostly mitomycin C) resulted in more diffuse fi ltering blebs 1 year postoperatively, although the surgical success rate was not different from control eyes (Lopes et al 2006) . Subconjunctival injection of Healon ® 5 was also effective in treating a small conjunctival break that was created during trabeculectomy with adjunctive mitomycin C and was technically difficult to close by suturing without compromising fi ltration (Higashide et al 2005) . The site of the leakage was successfully plugged in 3 consecutive cases by Healon ® 5 without suturing due to its superviscous cohesive properties at low shear rate. No leakage from the mildly elevated bleb was observed on the fi rst postoperative day and the technique was associated with no postoperative complications. One possible drawback of the intraoperative injection of sodium hyaluronate during trabeculectomy is the early postoperative IOP rise which is especially dangerous to eyes with advanced visual fi eld loss (Liebmann et al 1990; Barak et al 1992) . Close monitoring of the postoperative IOP is necessary, even though the removal of sodium hyaluronate from the anterior chamber at the conclusion of the surgery may decrease the risk of an IOP rise (Shin et al 2003) .
Trabeculectomy -postoperative use of sodium hyaluronate Intracameral injection of sodium hyaluronate is reported to be useful to treat a postoperative shallow or fl at anterior chamber (Gerber and Cantor 1990; Juzych et al 1992; Osher et al 1996; Salvo et al 1999) . A survey reported in 1999 revealed that 75% of American Glaucoma Society members used sodium hyaluronate (most commonly Healon ® ) for anterior chamber reformation (Salvo et al 1999) . However, the effect of sodium hyaluronate sometimes does not last long and repeated injection or alternative methods are then required. In expectation of a more prolonged stay and, therefore, better stabilization of the anterior chamber, Healon ® 5 was used for reformation of a flat anterior chamber with inconsistent success (Hoffman et al 2002; Geyer et al 2003; Gutierrez-Ortiz and Moreno-Lopez 2003) . For cases in which Healon ® or Healon ® 5 was ineffective, combined intracameral injection of sulfur hexafl uoride, a long-acting gas, and Healon ® successfully stabilized the anterior chamber (Geyer et al 2003) . A similar technique using perfl uoropropane and an OVD was also reported (Kurtz and Leibovitch 2002) . For postoperative hypotony, intracameral injection of Healon ® 5 raised IOP to an extent insuffi cient to fully improve the hypotonus conditions (Altangerel et al 2006) .
Goniotomy
The effectiveness of sodium hyaluronate in keeping suffi cient depth of the anterior chamber also facilitates goniotomy. Arnoult et al (1988) reported that sodium hyaluronate injected intracamerally during goniotomy prevented accidental loss of the anterior chamber, allowed maximal depth of the anterior chamber, diminished intraocular bleeding, and lowered the risk of injury to ocular tissues. In a retrospective study comparing goniotomy with and without Healon ® , the authors concluded that the use of sodium hyaluronate may increase the success rate and decrease the complication rate by preventing hyphema and fl attening of the anterior chamber (Tamcelik and Ozkiris 2004) . Intracameral injection of sodium hyaluronate into the anterior chamber may also facilitate goniosynechialysis, another type of goniosurgery. ). The presence of OVD in the Schlemm's canal was supposed to prevent fi brosis at the ostia adjacent to the subscleral space. It is not known whether the extent of the dilatation of Schlemm's canal affects surgical success. In viscocanalostomy experiments with human eyes obtained at autopsy, the more viscous Healon ® 5 was superior to Healon GV ® in dilating Schlemm's canal 6.0 mm from the fl ap (Wild et al 2001) . Experimental viscocanalostomy in rhesus monkey resulted in microperforation in the endothelial lining of Schlemm's canal that was attributed to the increase in outfl ow facility (Tamm et al 2004) . The authors indicated that the persistence of endothelial defects in Schlemm's canal 1 to 2 months after surgery may be caused by the inhibitory effects of sodium hyaluronate on thrombocyte aggregation. In another application of sodium hyaluronate in nonpenetrating glaucoma surgery, SKGEL ® , a reticulated hyaluronic acid implant, was developed for preserving the space under the scleral fl ap in non-penetrating deep sclerectomy (Sourdille et al 1999) . In a study evaluating the effect of SKGEL ® in non-penetrating deep sclerectomy, IOP control was better with SKGEL ® than without it (Detry-Morel 2001). SKGEL ® was also applied in viscocanalostomy, but a prospective randomized trial in patients with open angle glaucoma failed to show better surgical outcome with SKGEL ® when compared with standard viscocanalostomy (Luke et al 2003) .
Corneal transplantation
Sodium hyaluronate is also indispensable to corneal transplantation surgery in several respects including protection of donor corneal endothelial cells (Frost et al 2006) . In a case with corneal perforation, trephination of the host cornea is diffi cult due to hypotony. Healon ® 5 injected into the anterior chamber temporarily closed the corneal wound and facilitated the trephination (Rado and Berta 2002) . Healon ® 5 also facilitates deep lamellar keratoplasty in diffi cult cases such as keratoconus that have a relatively high risk of rupturing Descemet's membrane during surgery (Shimmura et al 2005) . In the visco-dissection technique to separate Descemet's membrane from posterior stroma (Melles et al 1999A; Melles et al 2000) , Healon ® 5 enabled precise control of visco-dissection and caused no Descemet's membrane ruptures in 4 cases (Shimmura et al 2005) .
Vitreoretinal surgery
Prior to its widespread use for IOL implantation, sodium hyaluronate was used as a substitute for the vitreous in retinal detachment surgery (Balazs et al 1972) . Since then, there have been a number of reports of the usefulness of sodium hyaluronate in vitreoretinal surgery. Although sodium hyaluronate as an intraoperative tamponade in diffi cult cases (Pruett et al 1979) has mostly been replaced by perfl uorocarbon liquids (Chang 1987) , viscodissection or viscodelamination using sodium hyaluronate is still an effective surgical technique in vitreoretinal surgery (McLeod and James 1988; Grigorian et al 2003) .
Recent application of sodium hyaluronate in vitrectomy is for protection of the retina from chemical or mechanical damages. Staining with indocyanine green facilitates visualization and peeling of the internal limiting membrane in eyes with macular holes (Kadonosono et al 2000) and other vitreomacular interface abnormalities. The original preparation of indocyanine green for internal limiting membrane peeling was a mixture of the dye and a low molecular weight OVD (fi nal concentration, 0.06%; osmolarity, 270 mOsm) (Kadonosono et al 2000) . Later, a number of clinical and experimental studies raised the possibility of toxicity of indocyanine green to the retinal pigment epithelium (Engelbrecht et al 2002; Ho et al 2003) and to retinal ganglion cells (Iriyama et al 2004; Yamashita et al 2006) , and a reduction of the concentration and duration of dye exposure was recommended. In this regard, sodium hyaluronate 2.3% placed over the macular hole effectively prevented the subretinal migration of indocyanine green through the hole during vitrectomy for retinal detachment with a myopic macular hole (Cacciatori et al 2004) . A similar technique was also reported for prevention of the contact between indocyanine green and the retinal pigment epithelium in a macular hole (Saito and Iida 2006) . Regarding mechanical protection of the retina, Hanemoto et al (2004) reported that intravitreously injected Healon ® 5, which covered the posterior pole, prevented retinal damage during removal of a luxated crystalline lens by intravitreal phacoemulsifi cation. 
